心脉医疗
(688016)
| 流通市值：123.26亿 | | | 总市值：123.26亿 |
| 流通股本：1.23亿 | | | 总股本：1.23亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,014,780,041.62 | 714,429,779.98 | 332,189,385.86 | 1,206,326,728.85 |
| 营业收入 | 1,014,780,041.62 | 714,429,779.98 | 332,189,385.86 | 1,206,326,728.85 |
| 二、营业总成本 | 563,934,629.28 | 389,156,547.64 | 183,356,645.13 | 663,428,424.66 |
| 营业成本 | 300,378,868.65 | 220,133,977.1 | 100,944,833.74 | 325,577,170.52 |
| 税金及附加 | 9,126,229.19 | 7,539,135.13 | 3,463,866.56 | 10,477,237.42 |
| 销售费用 | 151,418,849.43 | 95,878,769.37 | 44,684,383.34 | 156,846,814.45 |
| 管理费用 | 59,946,902.97 | 37,380,684.6 | 20,228,541.7 | 93,405,838.97 |
| 研发费用 | 50,922,215.9 | 36,976,562.01 | 15,941,366.59 | 93,769,544.44 |
| 财务费用 | -7,858,436.86 | -8,752,580.57 | -1,906,346.8 | -16,648,181.14 |
| 其中:利息费用 | 1,812,553.23 | 1,113,875 | 951,200.99 | 1,648,780.8 |
| 其中:利息收入 | 9,015,824.04 | 6,229,719.77 | 3,157,648.33 | 17,090,466.76 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 11,603,285.95 | 7,659,856.97 | 4,226,177.26 | 87,410,584.23 |
| 资产处置收益 | - | - | - | 25,522.26 |
| 资产减值损失(新) | -7,574,592.91 | -3,850,457.37 | -1,263,238.02 | -4,689,643.46 |
| 信用减值损失(新) | -14,004,888.85 | -6,881,898.82 | -5,472,001.31 | -3,246,874.58 |
| 其他收益 | 56,593,737.7 | 44,905,553.42 | 4,547,610.03 | 38,774,540.21 |
| 四、营业利润 | 497,462,954.23 | 367,106,286.54 | 150,871,288.69 | 661,172,432.85 |
| 加:营业外收入 | 312,818.03 | 872.03 | 172.02 | 59,548.78 |
| 减:营业外支出 | 232,740.32 | 171,467.45 | 5,877.21 | 9,038,063.29 |
| 五、利润总额 | 497,543,031.94 | 366,935,691.12 | 150,865,583.5 | 652,193,918.34 |
| 减:所得税费用 | 74,477,858.8 | 56,310,798.71 | 22,869,874.62 | 159,445,587.35 |
| 六、净利润 | 423,065,173.14 | 310,624,892.41 | 127,995,708.88 | 492,748,330.99 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 423,065,173.14 | 310,624,892.41 | 127,995,708.88 | 492,748,330.99 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 429,055,896.79 | 314,647,223.94 | 129,636,898.33 | 502,100,205.69 |
| 少数股东损益 | -5,990,723.65 | -4,022,331.53 | -1,641,189.45 | -9,351,874.7 |
| 扣除非经常损益后的净利润 | 372,382,494.57 | 270,825,612.26 | 122,361,708.78 | 395,496,629.62 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 3.54 | 2.55 | 1.05 | 4.07 |
| (二)稀释每股收益 | 3.54 | 2.55 | 1.05 | 4.07 |
| 八、其他综合收益 | 38,052,254.42 | 38,073,084.01 | -3,262,364.66 | -15,299,903.88 |
| 归属于母公司股东的其他综合收益 | 38,052,254.42 | 38,073,084.01 | -3,262,364.66 | -15,299,903.88 |
| 九、综合收益总额 | 461,117,427.56 | 348,697,976.42 | 124,733,344.22 | 477,448,427.11 |
| 归属于母公司股东的综合收益总额 | 467,108,151.21 | 352,720,307.95 | 126,374,533.67 | 486,800,301.81 |
| 归属于少数股东的综合收益总额 | -5,990,723.65 | -4,022,331.53 | -1,641,189.45 | -9,351,874.7 |
| 公告日期 | 2025-10-30 | 2025-08-27 | 2025-04-30 | 2025-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |